How can you diffrentiate psychiatric feature due to Neurological disease (Autoimmune, Paraneopladtic, infection, Seizure) vs true psychiatric disorder like Psychosis, schizophrenia
differentiating organic neurological psychiatric features from primary psychiatric disorder psychosis schizophrenia
Diagnosis and Management of Wilson Disease
Page 4
autoimmune encephalitis paraneoplastic psychiatric symptoms anti-NMDA receptor psychosis diagnosis
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 2818
red flags organic cause secondary psychosis neurological workup investigations EEG MRI CSF
seizure related psychiatric symptoms ictal postictal psychosis interictal psychosis schizophrenia-like
| Red Flag Category | Specific Features |
|---|---|
| Age & onset | First psychosis after age 40, or before age 12 |
| Acuity | Rapid onset over hours-days (vs. insidious onset over months) |
| Consciousness/cognition | Fluctuating consciousness, acute confusional state, prominent memory impairment |
| Neurological signs | Focal deficits, abnormal movements (dyskinesias, dystonia), cranial nerve palsies, ataxia, aphasia |
| Seizures | New-onset seizures concurrent with psychiatric symptoms |
| Autonomic instability | Tachycardia, fever, labile BP, hypersalivation |
| Sleep disruption | Severe insomnia as an early prominent feature |
| No psychiatric history | No personal or family history of psychiatric illness |
| Poor antipsychotic response | Minimal or atypical response to standard doses |
| Systemic illness | Preceding viral prodrome, known malignancy, systemic autoimmune disease |
| Medication/substance | Temporal relation to a drug, toxin, or new medication |
The disorder has a characteristic pattern of symptom progression that often includes a prodrome resembling a viral process, followed in a few days by the onset of severe psychiatric symptoms, sleep dysfunction (usually insomnia), reduced verbal output, memory loss, seizures, decreased level of consciousness, abnormal movements (orofacial, limb, and trunk dyskinesias, dystonic postures), autonomic instability, and frequent hypoventilation.
| Feature | Anti-NMDA Encephalitis | Schizophrenia |
|---|---|---|
| Onset | Acute/subacute (days-weeks) | Insidious (months-years) |
| Age/sex | Young women, children predominantly | Equal sex distribution in early onset |
| Psychiatric features | Psychosis + agitation + catatonia in combination | Positive symptoms predominate |
| Cognitive decline | Early, prominent, rapid | Late in disease course |
| Seizures | Common, early | Rare (unless on clozapine) |
| Abnormal movements | Orofacial dyskinesias, opisthotonus | Tardive dyskinesia only after antipsychotic use |
| Autonomic instability | Prominent (fever, tachy, hypoxia) | Absent |
| Consciousness | Decreased level of consciousness | Preserved |
| CSF | Lymphocytic pleocytosis in majority | Normal |
| EEG | Diffuse slowing, extreme delta brush pattern | Usually normal |
| MRI | 35% show medial temporal/FLAIR changes | Usually normal |
| Antibodies | NMDA-R IgG positive (serum/CSF) | Negative |
| Tumor association | Ovarian teratoma in ~50% of young women | None |
| Antibody | Associated Tumor | Dominant Features |
|---|---|---|
| Anti-Hu (ANNA-1) | SCLC | Limbic encephalitis, sensory neuropathy |
| Anti-Yo (PCA-1) | Ovarian, breast | Cerebellar degeneration |
| Anti-Ri (ANNA-2) | Breast, SCLC | Opsoclonus-myoclonus, brainstem |
| Anti-Ma2 | Testicular | Limbic + diencephalic encephalitis |
| Anti-CV2/CRMP5 | SCLC, thymoma | Limbic, chorea, neuropathy |
| Anti-amphiphysin | Breast, SCLC | Stiff person syndrome |
Cases were reported where patients carried the diagnosis of schizophrenia for years prior to their WD diagnosis.
| Type | Timing | Duration | Features |
|---|---|---|---|
| Ictal psychosis | During seizure activity | Seconds-minutes | Stereotyped, brief, associated with altered consciousness; non-goal-directed behavior |
| Postictal psychosis | 12-72 hrs after a cluster of seizures (lucid interval) | Days to weeks | Grandiose/paranoid delusions, aggression, visual hallucinations; self-limiting |
| Interictal psychosis | Between seizures, no temporal link | Weeks-months | Most resembles schizophrenia ("schizophrenia-like psychosis of epilepsy"); temporal lobe epilepsy especially |
| Feature | Favoring Primary Psychiatric (e.g., Schizophrenia) |
|---|---|
| Onset | Insidious, prodromal phase over months |
| Age | 18–35 years, gradual deterioration |
| Consciousness | Fully preserved throughout |
| Neurological exam | Normal |
| Negative symptoms | Prominent (flat affect, alogia, avolition, anhedonia) |
| Thought disorder | Formal thought disorder (loosening of associations, tangentiality) |
| Hallucinations | Predominantly auditory, third-person voices, commenting |
| MRI brain | Normal (or subtle diffuse changes, not focal) |
| EEG | Normal |
| CSF | Normal |
| Labs | All normal |
| Family history | Often positive for psychotic or affective disorder |
| Antipsychotic response | Good initial response to dopamine antagonists |
| Feature | Autoimmune/Paraneoplastic | Infectious | Seizure-related | Primary Psychosis (Schizophrenia) |
|---|---|---|---|---|
| Onset | Acute–subacute | Acute (with fever) | Related to seizure clusters | Insidious |
| Consciousness | Often impaired | Impaired | Impaired peri-ictally | Preserved |
| Seizures | Common | Common (HSV) | Defining feature | Rare |
| Abnormal movements | Yes (dyskinesias) | Rarely | Rarely | Only with antipsychotics |
| Fever/systemic signs | May be present | Present | Absent | Absent |
| Memory impairment | Early, prominent | Present | Post-ictal | Late |
| Negative symptoms | Absent | Absent | Absent | Prominent |
| MRI | Often abnormal | Often abnormal (temporal) | May show epileptogenic lesion | Usually normal |
| EEG | Encephalopathic/delta brush | PLEDs (HSV) | Epileptiform | Usually normal |
| CSF | Pleocytosis ± antibodies | Pleocytosis, PCR+ | Usually normal | Normal |
| Serum/CSF antibodies | Diagnostic | N/A | N/A | Negative |
| Tumor workup | Essential | Not needed | Not needed | Not needed |
| Treatment | Immunotherapy/oncology | Antivirals/antibiotics | AEDs | Antipsychotics |
Can a patient with TBM in which ATT started 2 month back have devolps psychaitric disorder?
tuberculous meningitis psychiatric symptoms psychosis neuropsychiatric complications
Treatment of Drug-Susceptible Tuberculosis
Page 32
anti-tuberculosis treatment isoniazid ethambutol psychiatric side effects psychosis
isoniazid neuropsychiatric toxicity psychosis seizure pyridoxine deficiency
TBM paradoxical reaction tuberculoma hydrocephalus vasculitis delayed complications on treatment
| Complication | Mechanism | Psychiatric Manifestation |
|---|---|---|
| Hydrocephalus | Arachnoid adhesions blocking CSF flow | Cognitive slowing, behavioral change, psychosis, personality change |
| Tuberculous vasculitis | Endarteritis of perforating vessels → infarcts | Focal deficits + delirium, mood change, psychosis depending on territory |
| Tuberculoma formation | Granuloma enlargement during treatment (paradoxical reaction) | Depends on location — frontal/temporal tuberculoma → behavioral/psychotic features |
| Direct limbic/cortical involvement | TBM commonly involves the base of brain and can extend to cortex | Memory impairment, personality change, psychosis |
| SIADH | TBM-associated hypothalamic dysfunction → hyponatremia | Confusion, behavioral change, seizures |
Key point: Hydrocephalus and vasculitis are the two most common causes of neurological deterioration in TBM patients who are already on treatment. Both can present primarily as psychiatric features.
| Mechanism | Effect |
|---|---|
| Pyridoxine (B6) depletion | Inhibits B6 metabolism → GABA synthesis impaired → seizures, psychosis, encephalopathy |
| Direct neurotoxicity | Especially at higher doses or in slow acetylators |
| Drug-drug interaction | INH inhibits CYP2E1/2C19 — raises levels of co-administered drugs |
| Cause | Mechanism | Notes |
|---|---|---|
| Hyponatremia (SIADH) | Very common in TBM | Confusion, behavioral change, psychosis at Na+ <125 mEq/L |
| Hepatotoxicity (ATT-induced) | INH + RIF + PZA all hepatotoxic | Encephalopathy if liver fails |
| Adrenal insufficiency | TB adrenalitis (rare) or relative insufficiency | Behavioral change, fatigue, confusion |
| Malnutrition | TB is catabolic; B12/folate deficiency | Cognitive + psychiatric features |
| Anemia | Chronic disease + drug-induced | Fatigue, cognitive slowing |
| Test | Looking For |
|---|---|
| Serum Na+, K+, glucose, BUN, creatinine | Hyponatremia (SIADH), metabolic cause |
| LFTs | ATT hepatotoxicity → encephalopathy |
| CBC | Infection, anemia |
| Serum B6 (pyridoxine) levels | INH toxicity |
| Serum ammonia | Hepatic encephalopathy |
| Drug levels (if cycloserine) | Cycloserine toxicity |
| MRI brain with contrast | Hydrocephalus, new/enlarging tuberculomas, vasculitic infarcts, paradoxical reaction |
| EEG | Subclinical seizures driving psychiatric features |
| Repeat CSF (if safe) | Treatment response, new superinfection, ICP |
| Cortisol | Adrenal insufficiency |
| Diagnosis | Action |
|---|---|
| Hydrocephalus | Neurosurgical consult (EVD/VP shunt) |
| Vasculitic infarct | Continue ATT + steroids, optimize anticoagulation if indicated |
| INH toxicity | Increase pyridoxine to 100–200 mg/day; consider dose reduction or switch |
| Cycloserine toxicity | Dose reduction or discontinuation; pyridoxine; switch drug |
| Hyponatremia | Fluid restriction, correct Na+ carefully |
| Paradoxical reaction | Corticosteroids (if not on them) or increase current dose |
| Steroid psychosis | Taper more slowly; consider short-term antipsychotic if severe |
| ATT hepatotoxicity | Suspend hepatotoxic drugs (PZA first, then INH, then RIF); liver-sparing regimen |
TBM patient on ATT × 2 months → new psychiatric symptoms
│
┌──────────────┼───────────────┐
▼ ▼ ▼
Drug toxicity Disease Systemic
(INH/Cyclo- complication complication
serine/ │ │
Steroids) ├─ Hydrocephalus (MRI)
│ ├─ Vasculitis/infarct (MRI/DWI)
│ ├─ Paradoxical tuberculoma
│ └─ Limbic/cortical TBM
│ │
│ └─ Hyponatremia (SIADH)
│ ATT hepatotoxicity
│ Adrenal insufficiency
▼
Check: Is patient on cycloserine? → High priority
Check: Is pyridoxine prescribed? → If not, INH toxicity likely
Check: Steroid dose/taper stage? → Steroid psychosis